Save over 60% with Striverdi Respimat from Boehringer.
Information about Striverdi Respimat (Olodaterol)
Striverdi Respimat is a medication used to treat chronic obstructive pulmonary disease (COPD), which includes conditions like chronic bronchitis and emphysema. It contains the active ingredient olodaterol, a long-acting beta-agonist (LABA) that helps open the airways in the lungs, making it easier to breathe.
Product Highlights
- Striverdi Respimat is primarily prescribed for the long-term maintenance treatment of COPD to help improve lung function and reduce symptoms like shortness of breath and wheezing.
Key Ingredient
Key Benefits
- Provides sustained bronchodilation for up to 24 hours, helping patients breathe more easily throughout the day and night.
- Regular use of Striverdi Respimat can improve lung function, which helps reduce symptoms of COPD such as shortness of breath.
- Since it is typically taken once daily, it helps patients stick to their treatment plan more easily compared to medications requiring multiple doses per day.
- The Respimat inhaler is easy to use, and it delivers a fine mist, which can be more effective for some patients compared to traditional inhalers.
Direction of Use
- Before first use, the Respimat inhaler must be primed to ensure accurate dosing.
- Inhale one puff (or dose) of Striverdi Respimat once daily. It is important to follow the instructions for inhaler technique closely to ensure proper medication delivery.
- Striverdi Respimat should be used consistently every day, even if you feel well, to maintain control of your COPD symptoms.
Safety Concerns
- Striverdi Respimat is not intended to treat sudden breathing problems or asthma attacks. It should not be used as a rescue inhaler.
- Some patients may experience side effects such as throat irritation, cough, headache, dizziness, or a rapid heart rate.
- Long-acting beta-agonists (LABAs) may increase the risk of asthma-related deaths when used alone for asthma treatment. Therefore, Striverdi Respimat should not be used for asthma unless prescribed alongside an inhaled corticosteroid (ICS) in patients with asthma.
- Caution is needed for patients with heart conditions such as arrhythmia or high blood pressure, as beta-agonists can affect heart rate and rhythm.
- Striverdi Respimat may interact with other medications, especially other beta-agonists or medications that affect heart rhythm.
Avoid Striverdi Respimat (Olodaterol) If
- You are allergic to olodaterol or any other ingredients in the formulation.
- You are using other LABAs for the treatment of asthma or COPD.
- You are experiencing acute bronchospasm or a sudden asthma attack.
- You have a history of severe allergic reactions to other medications, including inhaled beta-agonists.
- You have a history of heart problems such as arrhythmias, angina, or high blood pressure that is poorly controlled, as Striverdi Respimat may exacerbate these conditions.
